EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Ability to remotely monitor atrial high-rate episodes using a single-chamber implantable cardioverter-defibrillator with a floating atrial sensing dipole

Gerhard Hindricks iD, Dominic A Theuns iD, David Bar-Lev iD, Ignasi Anguera iD, Félix Alejandro Ayala Paredes iD, Martin Arnold, J Christoph Geller, Béla Merkely, Katia Marjolaine Dyrda iD, Christian Perings, Giampiero Maglia iD, Sylvain Ploux iD und 10 weitere

Europace · 2023

DOI: 10.1093/europace/euad061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Europace, 2023. Verfasst von Gerhard Hindricks und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrophysiology, Heart Centre Leipzig and Leipzig Heart Institute, Strümpellstrasse 39, 04289 Leipzig, Germany. Hauptthemen laut MEDLINE: Atrial Fibrillation, Defibrillators, Implantable, Stroke. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Biotronik.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To allow timely initiation of anticoagulation therapy for the prevention of stroke, the European guidelines on atrial fibrillation (AF) recommend remote monitoring (RM) of device-detected atrial high-rate episodes (AHREs) and progression of arrhythmia duration along pre-specified strata (6 min…<1 h, 1 h…<24 h, ≥ 24 h). We used the MATRIX registry data to assess the capability of a single-lead implantable cardioverter-defibrillator (ICD) with atrial sensing dipole (DX ICD system) to follow this recommendation in patients with standard indication for single-chamber ICD. Methods and results In 1841 DX ICD patients with daily automatic RM transmissions, electrograms of first device-detected AHREs per patient in each duration stratum were adjudicated, and the corresponding positive predictive values (PPVs) for the detections to be true atrial arrhythmia were calculated. Moreover, the incidence and progression of new-onset AF was assessed in 1451 patients with no AF history. A total of 610 AHREs ≥6 min were adjudicated. The PPV was 95.1% (271 of 285) for episodes 6min…<1 h, 99.6% (253/254) for episodes 1 h…<24 h, 100% (71/71) for episodes ≥24 h, or 97.5% for all episodes (595/610). The incidence of new-onset AF was 8.2% (119/1451), and in 31.1% of them (37/119), new-onset AF progressed to a higher duration stratum. Nearly 80% of new-onset AF patients had high CHA2DS2-VASc stroke risk, and 70% were not on anticoagulation therapy. Age was the only significant predictor of new-onset AF.

Conclusion

A 99.7% detection accuracy for AHRE ≥1 h in patients with DX ICD systems in combination with daily RM allows a reliable guideline-recommended screening for subclinical AF and monitoring of AF-duration progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationDefibrillators, ImplantableStrokeHumansHeart AtriaAnticoagulants

Stichwörter der Autor:innen

AHREAtrial fibrillationDX ICDRemote monitoringRisk of strokeSingle-lead ICD with atrial sensing

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Electrophysiology, Heart Centre Leipzig and Leipzig Heart Institute, Strümpellstrasse 39, 04289 Leipzig, Germany.
  • Erasmus University Medical Center, 's-Gravendijkwal 230, 3015 GD Rotterdam, The Netherlands.
  • Chaim Sheba Medical Center, 52621 Tel Hashomer, Israel.
  • Arrhythmia Unit, Heart Diseases Institute, Bellvitge Biomedical Research Institute (IDIBELL), Bellvitge University Hospital, Feixa Llarga, 08907 L'Hospitalet, Barcelona, Spain.
  • Sherbrooke University Hospitals (CHUS), 3001 12e Avenue Nord, J1H 5N4 Sherbrooke, Quebec, Canada.
  • Department of Cardiology, Friedrich-Alexander-Universität Erlangen-Nuremberg, Ulmenweg 18, 91054 Erlangen, Germany.

ORCID-Profile: Gerhard Hindricks, Dominic A Theuns, David Bar-Lev, Ignasi Anguera, Félix Alejandro Ayala Paredes, Katia Marjolaine Dyrda, Giampiero Maglia, Sylvain Ploux, Carina Blomström-Lundqvist, Yanchun Liang, Igor Diemberger, Jerzy Krzysztof Wranicz, Fabio Quartieri, Tobias Timmel, Andreas Bollmann

Förderung

  • Biotronik

Zitieren

APA

Hindricks, G., Theuns, D. A., Bar-Lev, D., Anguera, I., Ayala Paredes, F. A., Arnold, M., Geller, J. C., Merkely, B., Dyrda, K. M., Perings, C., Maglia, G., Ploux, S., Meyhöfer, J., Blomström-Lundqvist, C., Karjalainen, P., Liang, Y., Diemberger, I., Wranicz, J. K., Barr, C., …, & Bollmann, A. (2023). Ability to remotely monitor atrial high-rate episodes using a single-chamber implantable cardioverter-defibrillator with a floating atrial sensing dipole. Europace. https://doi.org/10.1093/europace/euad061

Vancouver

Hindricks G, Theuns DA, Bar-Lev D, Anguera I, Ayala Paredes FA, Arnold M, et al. Ability to remotely monitor atrial high-rate episodes using a single-chamber implantable cardioverter-defibrillator with a floating atrial sensing dipole. Europace. 2023. doi:10.1093/europace/euad061

BibTeX
@article{Hindricks2023,
  author = {Hindricks, Gerhard and Theuns, Dominic A and Bar-Lev, David and Anguera, Ignasi and Ayala Paredes, Félix Alejandro and Arnold, Martin and Geller, J Christoph and Merkely, Béla and Dyrda, Katia Marjolaine and Perings, Christian and Maglia, Giampiero and Ploux, Sylvain and Meyhöfer, Jürgen and Blomström-Lundqvist, Carina and Karjalainen, Pasi and Liang, Yanchun and Diemberger, Igor and Wranicz, Jerzy Krzysztof and Barr, Craig and Quartieri, Fabio and Timmel, Tobias and Bollmann, Andreas},
  title = {Ability to remotely monitor atrial high-rate episodes using a single-chamber implantable cardioverter-defibrillator with a floating atrial sensing dipole},
  journal = {Europace},
  year = {2023},
  doi = {10.1093/europace/euad061}
}
Kostenlos starten →